Talphera Inc (TLPH) Actualités

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study

Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors

Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors PR...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire SAN MATEO...

Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024

Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday...